Immunoglobulin G4 Related Disease Igg4 Rd clinical trials

Explore recruiting immunoglobulin g4 related disease igg4 rd clinical trials.

Recruiting immunoglobulin g4 related disease igg4 rd studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Immunoglobulin G4 Related Disease Igg4 Rd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study of Inebilizumab Efficacy and Safety in IgG4-Related Disease.

Netherlands, Italy, Germany, Poland, Spain, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Open-label, Uncontrolled, Multicenter Trial to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Children From 2 Years to Less Than 18 Years of Age with Immunoglobulin G4 related Disease (IgG4-RD)

Greece, Poland, Italy, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Immunoglobulin G4 Related Disease Igg4 Rd trials by city

Immunoglobulin G4 Related Disease Igg4 Rd clinical trials

Recruiting immunoglobulin g4 related disease igg4 rd studies right now

A Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RD

the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases

Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease

A Randomized Controlled Study of the Efficacy and Safety of Lenalidomide in the Treatment of Active IgG4-related Disease

Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases

Short-term Glucocorticoid Combined with MMF for IgG4-RD

Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease

Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease

Also recruiting in Europe

A Phase 3, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study of Inebilizumab Efficacy and Safety in IgG4-Related Disease.

Open-label, Uncontrolled, Multicenter Trial to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Children From 2 Years to Less Than 18 Years of Age with Immunoglobulin G4 related Disease (IgG4-RD)

Immunoglobulin G4 Related Disease Igg4 Rd trials by city

Other conditions